RHBC
R.H. Bluestein & Co Portfolio holdings
AUM
$1.61B
This Quarter Return
+7.62%
1 Year Return
-7.59%
3 Year Return
+68.98%
5 Year Return
+139.54%
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(-5.7%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-9.47%
Top 10 Holdings %
Top 10 Hldgs %
36.91%
Holding
321
New
34
Increased
51
Reduced
91
Closed
31
Top Buys
| 1 |
B
Barrick Mining Corporation
B
|
$54.7M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$30M |
| 3 |
MON
Monsanto Co
MON
|
$20.5M |
| 4 |
Stryker
SYK
|
$16.9M |
| 5 |
Waste Management
WM
|
$15.2M |
Top Sells
| 1 |
GE Aerospace
GE
|
$28.3M |
| 2 |
Devon Energy
DVN
|
$27.2M |
| 3 |
U-Haul Holding Co
UHAL
|
$26.6M |
| 4 |
Gilead Sciences
GILD
|
$21.7M |
| 5 |
Boeing
BA
|
$21M |
Sector Composition
| 1 | Industrials | 15.6% |
| 2 | Materials | 14.21% |
| 3 | Communication Services | 12.45% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Discretionary | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caterpillar
CAT
$194B
| $27.9M | 2.13% |
367,599
+20,926
| +6% | +$1.59M |
|
27
Ford
F
$46.2B
| $23.6M | 1.81% |
1,877,928
-106,286
| -5% | -$1.34M |
|
28
Palo Alto Networks
PANW
$128B
| $22M | 1.69% |
179,722
+16,584
| +10% | +$2.03M |
|
|
MON
29
DELISTED
Monsanto Co
MON
| $20.5M | 1.57% |
+198,180
| New | +$20.5M |
|
30
Comcast
CMCSA
$125B
| $20.3M | 1.55% |
310,909
+64,080
| +26% | +$4.18M |
|
|
31
Stryker
SYK
$149B
| $18.4M | 1.41% |
153,963
+141,213
| +1,108% | +$16.9M |
|
32
Netflix
NFLX
$521B
| $15.8M | 1.21% |
173,234
-3,839
| -2% | -$351K |
|
33
Hanesbrands
HBI
$2.17B
| $15.1M | 1.15% |
598,909
+2,148
| +0.4% | +$54K |
|
34
Pfizer
PFE
$141B
| $14.6M | 1.12% |
413,916
+395,328
| +2,127% | +$13.9M |
|
|
AGN
35
DELISTED
Allergan plc
AGN
| $11.9M | 0.91% |
51,326
+48,299
| +1,596% | +$11.2M |
|
36
Coca-Cola
KO
$297B
| $5.96M | 0.46% |
131,413
-184,040
| -58% | -$8.34M |
|
|
MBLY
37
DELISTED
Mobileye N.V.
MBLY
| $4.96M | 0.38% |
107,500
+87,500
| +438% | +$4.04M |
|
|
HES
38
DELISTED
Hess
HES
| $4.66M | 0.36% |
77,550
-129,075
| -62% | -$7.76M |
|
39
Berkshire Hathaway Class A
BRK.A
$1.08T
| $3.04M | 0.23% |
14
-14
| -50% | -$3.04M |
|
40
Johnson & Johnson
JNJ
$429B
| $2.8M | 0.21% |
23,066
+4,496
| +24% | +$545K |
|
41
Eli Lilly
LLY
$661B
| $2.58M | 0.2% |
+32,775
| New | +$2.58M |
|
42
Newmont
NEM
$82.8B
| $2.27M | 0.17% |
+58,050
| New | +$2.27M |
|
43
IBM
IBM
$227B
| $1.93M | 0.15% |
12,706
+1,000
| +9% | +$152K |
|
44
BP
BP
$88.8B
| $1.47M | 0.11% |
41,450
+16,450
| +66% | +$584K |
|
45
Chubb
CB
$111B
| $1.47M | 0.11% |
11,250
+8,750
| +350% | +$1.14M |
|
46
Novartis
NVS
$248B
| $1.25M | 0.1% |
15,100
-100
| -0.7% | -$8.21K |
|
47
SPDR S&P 500 ETF Trust
SPY
$656B
| $1.24M | 0.09% |
5,914
+806
| +16% | +$169K |
|
48
SPDR Gold Trust
GLD
$111B
| $1.13M | 0.09% |
8,966
-2,050
| -19% | -$259K |
|
49
GSK
GSK
$79.3B
| $1.09M | 0.08% |
25,164
| – | – |
|
50
Novo Nordisk
NVO
$252B
| $1.08M | 0.08% |
20,000
-5,000
| -20% | -$269K |
|